Metabolomics Market sales is growing at 25.0% CAGR till 2021
Deerfield Beach, FL -- (SBWIRE) -- 12/04/2017 -- According to the report, the global demand for metabolomics is expected to reach above USD 2,500.0 million in 2021, growing at a CAGR of above 25.0% till 2021.
Metabolism is the chemical reaction of the cell or tissue to maintain the living state of the cell. Metabolism can be either anabolism or catabolism. Anabolism is the process in which compounds are synthesized that is required for cells to process, while the breakdown of molecules for releasing energy is the catabolism. The metabolome is the set of metabolites like signaling molecules, hormones metabolic intermediates and secondary metabolites, present in a single organism. Metabolomics is a study of chemical reactions related to metabolites and a field of analytical biochemistry.Metabolomics is used to quantify and identify the metabolites present in the cell by using the analytical technologies coupled with the multi-variant and statistical method for data interpretation.
Black Friday Deal: Flat 30% off on all reports
Development of metabolomics data analysis software and biomarker screening of diseases metabolomics is used as diagnostic tool contributes to the splendid growth of metabolomics market. Moreover increasing the scope of toxicological studies, clinical trials, rise in awareness for health and government and institution funds for research drives the demand for the metabolomics market. Validation of the process and lack of adoption of metabolomics technology is the major restraint of the metabolomics market. Untapped demand from emerging economies and surging research and development expenditure are likely to open new market avenues in the near future.
The metabolomics market is segmented on basis of technology, indication, application, and region.Mass spectrometry, capillary electrophoresis, high-performance liquid chromatography, gas chromatography, and nuclear magnetic resonance spectroscopy are the technologies for metabolomics market.
Request For Free Sample Report: https://goo.gl/5YhspS
High-performance liquid chromatography segment accounted the highest share of metabolomics market. Applications include drug discovery, biomarker, and nutrigenomics. Drug discovery emerged as potential segment owing to its important role in optimization, prioritization, and drug target validation and identification for research. Cardiology and oncology are the indications for metabolomics.
With over 40%shares in total, metabolomics market was dominated by North America in 2015. This region is expected to be the fastest-growing market in near future. Europe was the second largest market for metabolomics in 2015. Asia Pacific is expected to witness rapid CAGR during the forecast period. The key players in the metabolomics market include Danaher Corporation, Bruker Corporation, Waters Corporation, Metabolon, Inc., Agilent Technologies, Thermo Fisher Scientific and Shimadzu Corporation among others.
Browse the full report at http://www.marketresearchstore.com/report/metabolomics-market-z55501
About Zion Market Research
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.